Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Completion of a Trial Protocol to Study its Self Assembling Vaccine to Target Prostate Stem Cell Antigen

2025-06-17T09:39:28-04:00

Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Completion [...]